(Q36804759)

16 August 2017

1 reference

title

Intravenous immunoglobulin in the treatment of spontaneously acquired factor VIII:C inhibitors (English)

1 reference

16 August 2017

Sultan Y

1

1 reference

16 August 2017

Kazatchkine MD

2

1 reference

16 August 2017

Nydegger U

3

1 reference

16 August 2017

Rossi F

4

1 reference

16 August 2017

Dietrich G

5

1 reference

16 August 2017

Algiman M

6

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 November 1991

1 reference

American Journal of Medicine

16 August 2017

1 reference

16 August 2017

91

1 reference

16 August 2017

5A

1 reference

16 August 2017

35S-39S

1 reference

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

16 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2891%2980147-E

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2891%2980147-E

Treatment of pure red cell aplasia by high dose intravenous immunoglobulins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2891%2980147-E

High-dose intravenous gammaglobulin for myasthenia gravis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2891%2980147-E

High-dose intravenous gammaglobulin for acquired von Willebrand's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2891%2980147-E

Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2891%2980147-E

Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2891%2980147-E

Effect of commercial immunoglobulin G preparation on human monocyte Fc-receptor dependent binding of antibody coated platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2891%2980147-E

High-dose intravenous IgG in adults with autoimmune thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2891%2980147-E

Haemophilia due to factor VIII inhibitors in a patient suffering from an autoimmune disease: treatment with intravenous immunoglobulin. A case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2891%2980147-E

Intravenous IgG for patients with spontaneous inhibitor to Factor VIII

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2891%2980147-E

Failure of high-dose i.v. gammaglobulin in the treatment of spontaneously acquired factor VIII inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2891%2980147-E

Development of anti-idiotypic antibodies in a patient with a factor VIII autoantibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2891%2980147-E

10.1016/S0002-9343(91)80147-E

7 January 2021

Identifiers

DOI

1 reference

16 August 2017

1 reference